Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Cash flows from operating activities:
Net loss	$ (20,694)	$ (29,544)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation	7,716	8,204
Amortization of intangible assets	13,781	24,707
Provision for doubtful accounts and allowance for product returns	21	848
Stock-based compensation	9,328	12,120
Non-cash restructuring and related charges	2,578	4,463
Other non-cash charges	1,964	529
Changes in operating assets and liabilities, net
Accounts receivable	(5,926)	26,894
Inventories	6,344	5,259
Prepaid expenses and other assets	8,181	1,896
Accounts payable	4,907	(19,520)
Accrued compensation and benefits	(1,322)	(2,275)
Deferred revenue	(6,245)	(843)
Deferred distributor revenue, net of cost of sales to distributors	17,441	(14,618)
Other current and long term liabilities	5,887	793
Net cash provided by operating activities	43,961	18,913
Cash flows from investing activities:
Capital expenditures	(7,832)	(2,797)
Acquisition	(51,088)
Deposit related to future acquisition	(10,239)
Net cash used in investing activities	(69,159)	(2,797)
Cash flows from financing activities:
Borrowings under Revolving Facility		15,000
Borrowings under Term Loan	48,250
Loan fees on borrowings	(1,327)
Repayment of debt	(7,775)	(23,125)
Proceeds from issuance of common stock	9,180	4,460
Net cash provided by (used in) financing activities	48,328	(3,665)
Foreign currency effect on cash	28	(342)
Net increase in cash and cash equivalents	23,158	12,109
Cash and cash equivalents at beginning of period	94,122	76,225
Cash and cash equivalents at end of period	$ 117,280	$ 88,334